Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Mesothelioma
Related studies linked through entity extraction aliases.
Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Cardiac MRI Biomarker Testing (GCC 1618)
- Status
- TERMINATED
- Phase
- N/A
A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Staging Procedures to Diagnose Malignant Pleural Mesothelioma
- Status
- TERMINATED
- Phase
- N/A
Safety Study of MGD009 in B7-H3-expressing Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma
- Status
- TERMINATED
- Phase
- N/A
Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma
- Status
- TERMINATED
- Phase
- N/A
Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)
- Status
- COMPLETED
- Phase
- PHASE2
MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication
- Status
- WITHDRAWN
- Phase
- PHASE3
Isolated Thoracic Perfusion (ITP-F) for MPM
- Status
- COMPLETED
- Phase
- N/A
Intrapleural Cryotherapy for Malignant Pleural Mesothelioma
- Status
- TERMINATED
- Phase
- NA